Nicolas Dulphy

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

The SETD2 L1609P mutation found in leukemia disrupts methyltransferase activity and reduces histone H3K36 trimethylation.

The SETD2 L1609P mutation found in leukemia disrupts methyltransferase activity and reduces histone H3K36 trimethylation.

Journal: The Journal of biological chemistry

Published: July 28, 2025

The SETD2 L1609P mutation found in leukemia disrupts methyltransferase activity and reduces histone H3K36 trimethylation.

The SETD2 L1609P mutation found in leukemia disrupts methyltransferase activity and reduces histone H3K36 trimethylation.

Journal: The Journal of biological chemistry

Published: July 28, 2025

Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Journal: Blood

Published: December 23, 2024

CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

Journal: Science signaling

Published: October 29, 2024

A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies.

A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies.

Journal: Experimental hematology & oncology

Published: October 09, 2024

Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system.

Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system.

Journal: Scientific reports

Published: September 19, 2024

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.

Journal: Frontiers in immunology

Published: August 28, 2024

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.

Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.

Journal: HemaSphere

Published: January 31, 2024

Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M.

Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M.

Journal: Blood cancer journal

Published: October 14, 2023

Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis.

Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis.

Journal: JCI insight

Published: July 12, 2023

What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?

What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?

Journal: Leukemia

Published: January 27, 2023

Modulation of NK cell activation by exogenous calcium from alginate dressings in vitro.

Modulation of NK cell activation by exogenous calcium from alginate dressings in vitro.

Journal: Frontiers in immunology

Published: January 09, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026